Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Time-to-Manufacture Reduced by 30% Through Upperton’s Rapid Transfer Strategy  | Contract Pharma

What are you searching for?

Sign in
Case Studies

Time-to-Manufacture Reduced by 30% Through Upperton’s Rapid Transfer Strategy 

A biotech approached Upperton with a formulation developed externally by another CDMO.

Released By Upperton

A biotech approached Upperton with a formulation developed externally by another CDMO. The biotech wanted to accelerate clinical supply manufacturing for an upcoming trial. During the initial technical transfer, our team identified critical formulation deficiencies. 

Taking the time to reformulate would have put the future of the project at risk. Therefore, the challenge was to address the critical formulation deficiencies without extending the timeline of the project. 

As a result, Upperton conducted rapid batch manufacturing to assess formulation robustness and identify key deficiencies. Upon identification, we saw that these could be mitigated through processing parameter adjustments. 

To read more, download the Case Study below

Download Case Studies Now

Download Case Studies Now

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics